@article{7f4c9db45e7046c5937cda5031a8ca53,
title = "Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome",
keywords = "Hypomethylating agent, MDS, lenalidomide",
author = "\{The Korean Society of Haematology AML/MDS Working Party\} and Hawk Kim and Lee, \{Je Hwan\} and Lee, \{Won Sik\} and Inho Kim and Moon, \{Joon Ho\} and Choi, \{Chul Won\} and Lee, \{Ho Sup\} and Jinny Park and Yunsuk Choi and Shin, \{Ho Jin\} and Cho, \{Su Hee\} and Kim, \{Kyoung Ha\} and Kim, \{Sung Yong\} and Kim, \{Yoo Jin\}",
year = "2019",
doi = "10.1111/bjh.15991",
language = "English",
volume = "186",
pages = "e151--e155",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley and Sons Inc.",
number = "5",
}